Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 1
2013 2
2014 3
2015 1
2017 2
2020 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis.
Tilburg J, Coenen DM, Zirka G, Dólleman S, van Oeveren-Rietdijk AM, Karel MFA, de Boer HC, Cosemans JMEM, Versteeg HH, Morange PE, van Vlijmen BJM, Maracle CX, Thomas GM. Tilburg J, et al. Among authors: van oeveren rietdijk am. J Thromb Haemost. 2020 Jul;18(7):1714-1727. doi: 10.1111/jth.14835. Epub 2020 May 15. J Thromb Haemost. 2020. PMID: 32297475 Free PMC article.
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.
van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax PH, Rabelink TJ, van Zonneveld AJ. van Solingen C, et al. Among authors: van oeveren rietdijk am. J Cell Mol Med. 2009 Aug;13(8A):1577-85. doi: 10.1111/j.1582-4934.2008.00613.x. J Cell Mol Med. 2009. PMID: 19120690 Free PMC article.
LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic application.
Pont MJ, Hobo W, Honders MW, van Luxemburg-Heijs SA, Kester MG, van Oeveren-Rietdijk AM, Schaap N, de Boer HC, van Bergen CA, Dolstra H, Falkenburg JH, Griffioen M. Pont MJ, et al. Among authors: van oeveren rietdijk am. Haematologica. 2015 Oct;100(10):e419-22. doi: 10.3324/haematol.2015.125021. Epub 2015 Jun 11. Haematologica. 2015. PMID: 26069289 Free PMC article. No abstract available.
Conversion from calcineurin inhibitors to belatacept-based immunosuppressive therapy skews terminal proliferation of non-classical monocytes and lowers lymphocyte counts.
Bredewold OW, van Oeveren-Rietdijk AM, Florijn B, Rotmans JI, de Fijter JW, van Kooten C, van Zonneveld AJ, de Boer HC. Bredewold OW, et al. Among authors: van oeveren rietdijk am. Transpl Immunol. 2024 Feb;82:101976. doi: 10.1016/j.trim.2023.101976. Epub 2024 Jan 8. Transpl Immunol. 2024. PMID: 38199271 Free article. Clinical Trial.
Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.
Bijkerk R, van Solingen C, de Boer HC, van der Pol P, Khairoun M, de Bruin RG, van Oeveren-Rietdijk AM, Lievers E, Schlagwein N, van Gijlswijk DJ, Roeten MK, Neshati Z, de Vries AA, Rodijk M, Pike-Overzet K, van den Berg YW, van der Veer EP, Versteeg HH, Reinders ME, Staal FJ, van Kooten C, Rabelink TJ, van Zonneveld AJ. Bijkerk R, et al. Among authors: van oeveren rietdijk am. J Am Soc Nephrol. 2014 Aug;25(8):1710-22. doi: 10.1681/ASN.2013060640. Epub 2014 Mar 7. J Am Soc Nephrol. 2014. PMID: 24610930 Free PMC article.
15 results